Physician

Amarilis Sanchez-Valle, M.D.

According to 2025 Medicare claims, Amarilis Sanchez-Valle, M.D. (NPI: 1275841603) practices medical genetics and genomics in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is UNIVERSITY MEDICAL SERVICE ASSOCIATION INC (NPI: 1821038761) and primary practice location at 33606-3475. Sanchez-Valle is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Sanchez-Valle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 14 traditional Medicare patients, billed 32 HCPCS/CPT codes, and received $3,016 in Medicare payments. Part D data shows 128 prescription claims across 11 beneficiaries totaling $3,693,703 in drug costs, led by Ravicti (Glycerol Phenylbutyrate). Open Payments data shows 60 records totaling $453,608. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,319 and ending at $3,016. Concurrently, Part D prescription costs have risen steadily, from $154,770 to $3,693,703. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5K$3.0K2015 Medicare payment: $1,319 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,207 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,224 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,077 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,364 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,718 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,290 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,564 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,016 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151214$1,319
20161726$2,207
2017N/RN/RN/R
20181215$1,224
20191520$2,077
20201112$1,364
20211316$1,718
20221114$1,290
20231225$2,564
20241432$3,016

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.4M$4.8M2015 Drug cost: $154,770 (USD; Tot_Drug_Cst)2016 Drug cost: $324,595 (USD; Tot_Drug_Cst)2017 Drug cost: $1,202,289 (USD; Tot_Drug_Cst)2018 Drug cost: $1,737,742 (USD; Tot_Drug_Cst)2019 Drug cost: $1,607,446 (USD; Tot_Drug_Cst)2020 Drug cost: $4,035,527 (USD; Tot_Drug_Cst)2021 Drug cost: $4,834,465 (USD; Tot_Drug_Cst)2022 Drug cost: $4,399,845 (USD; Tot_Drug_Cst)2023 Drug cost: $3,628,592 (USD; Tot_Drug_Cst)2024 Drug cost: $3,693,703 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R15$154,770
2016N/R27$324,595
2017N/R61$1,202,289
2018N/R97$1,737,742
2019N/R96$1,607,446
2020N/R100$4,035,527
2021N/R116$4,834,465
202211137$4,399,845
202314122$3,628,592
202411128$3,693,703

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RavictiGlycerol Phenylbutyrate24712$2,294,932
VprivVelaglucerase Alfa15420$550,455
MiglustatMiglustat17510$358,477
Sodium PhenylbutyrateSodium Phenylbutyrate13325$100,900
PalynziqPegvaliase-Pqpz12336$96,133

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$27,593BioMarin Pharmaceutical Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.45$426,014BioMarin Pharmaceutical Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amarilis Sanchez-Valle, M.D.?

Tedicare shows public-source Medicare data for Amarilis Sanchez-Valle, M.D. (NPI 1275841603), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amarilis Sanchez-Valle, M.D. have ACO affiliation data?

Amarilis Sanchez-Valle, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Amarilis Sanchez-Valle, M.D.?

Amarilis Sanchez-Valle, M.D. is linked to UNIVERSITY MEDICAL SERVICE ASSOCIATION INC (billing NPI 1821038761) in the available physician profile data.

Does Amarilis Sanchez-Valle, M.D. have Open Payments data?

Amarilis Sanchez-Valle, M.D. has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.